Pharmacological analysis of the CCK(B)/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat

British Journal of Pharmacology

Volumn 119, Issue 7, 1996, Pages 1401-1410

  Hills, David M ^c   Gerskowitch, V Paul ^a   Roberts, Sonia P ^b   Welsh, Nicola J ^c   Shankley, Nigel P ^c   Black, James W ^c  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b James Black Foundation   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

CCK(B) gastrin receptors; Gastric acid secretion; Histamine; Pentagastrin

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; CHOLECYSTOKININ B RECEPTOR; FAMOTIDINE; GASTRIN ANTAGONIST; GASTRIN RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; PENTAGASTRIN; CHOLECYSTOKININ RECEPTOR; HISTAMINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; STOMACH ACID SECRETION; ANIMAL; BINDING COMPETITION; BIOLOGICAL MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENTEROCHROMAFFIN CELL; IN VITRO STUDY; KINETICS; METABOLISM; SECRETION; STIMULATION; STOMACH ACID; STOMACH MUCOSA; WISTAR RAT;

ANIMALS; BINDING, COMPETITIVE; ENTEROCHROMAFFIN CELLS; FAMOTIDINE; GASTRIC ACID; GASTRIC MUCOSA; HISTAMINE; HISTAMINE H2 ANTAGONISTS; KINETICS; MODELS, BIOLOGICAL; PENTAGASTRIN; RATS; RATS, WISTAR; RECEPTORS, CHOLECYSTOKININ; STIMULATION, CHEMICAL;

EID: 0029658268     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16052.x     Document Type: Article

References (43)

1. 2-receptor blockade on acid secretion in vitro. Eur. J. Pharmacol., 80, 217-224.
2. 2-receptor antagonists using an in vitro acid secretion assay. Br. J. Pharmacol., 68, 413-424.
3. BEINBORN, M., LEE, Y.-M., MCBRIDE E.W., QUINN, S.M. & KOPIN, A.S. (1993). A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists. Nature, 362, 348-350.
4. 2-receptor antagonists in the isolated mouse stomach. Br. J. Pharmacol., 86, 581-587.
5. BLACK, J.W., LEFF, P. & SHANKLEY, N.P. (1985b). Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach. Br. J. Pharmacol., 86, 589-599.
6. BLACK, J.W. & SHANKLEY, N.P. (1985). The isolated stomach preparation of the mouse: a physiological unit for pharmacological analysis. Br. J. Pharmacol., 86, 571-579.
7. B receptor gene. Biochem. Biophys. Res. Commun., 202, 947-953.
8. 2-antagonist, on the isolated whole rat stomach. J. Physiol., 258, 453-465.
9. BURNS, J.H. (1950). Biological Standardization. Oxford: Oxford University Press.
10. DIMALINE, R., EVANS, D. & DOCKRAY, G.J. (1993). Histidine decarboxylase (HDC) mRNA in the rat stomach is rapidly increased by distension, and by a post-prandial cholinergic reflex. Gastroenterology, 108, A963.
11. GADDUM, J.H. (1945). Lognormal distributions. Nature, 156, 463-466.
12. 125I]-BH-CCK8S in guinea-pig gastric glands and mouse and rat cortex assays: evidence for variable expression of two CCK/gastrin receptors. Br. J. Pharmacol., 114, 221P.
13. B/gastrin receptors involved in pentagastrin-stimulated gastric acid secretion in the isolated immature rat stomach. Br. J. Pharmacol., 117, 195P.
14. HUGHES, J., BODEN, P., COSTALL, B., DOMENEY, A., KELLY, E., HORWELL, D.C., HUNTER, J.C., PINNOCK, R.D. & WOODRUFF, G.N. (1990). Development of a class of selective cholecystokinin type-B receptor antagonists having potent anxiolytic activity. Proc. Natl. Acad. Sci. U.S.A., 87, 6728-6732.
15. ITO, M., IWATA, N., TANIGUCHI, T., MURAYAMA, T., CHIHARA, K. & MATSUI, T. (1994). Functional characterization of two cholecystokinin-B/gastrin receptor isoforms: A preferential splice donor site in the human receptor gene. Cell Growth & Differentiation, 5, 1127-1135.
16. ITO, M., MATSUI, T., TANIGUCHI, T., TSUKAMOTO, T., MURAYAMA, T., ARIMA, N., NAKATA, H., CHIBA, T. & CHIHARA, K. (1993). Functional characterization of a human brain cholecystokinin-B receptor. A trophic effect of cholecystokinin and gastrin. J. Biol. Chem., 268, 18300-18305.
17. JENKINSON, D.H. (1991). How do we describe competitive antagonists: three questions of usage. Trends Pharmacol. Sci., 12, 53-54.
18. KALINDJIAN, S.B., BUCK, I.M., DAVIES, J.M., DUNSTONE, D.J., HUDSON, M., LOW, C.M.R., MCDONALD, I.M., PETHER, M.J., STEEL, K.I.M., TOZER, M.J. & VINTER, J.G. (1996). Non-peptide cholecystokinin-B/gastrin receptor antagonists based on bicyclic, heteroaromatic skeletons. J. Med. Chem., 39, 1806-1816.
19. KOPIN, A.S., LEE, Y.-M., MCBRIDE, E.W., MILLER, L.J., LU, M., LIN, H.Y., KOLAKOWSKI, Jr, L.F. & BEINBORN, M. (1992). Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc. Natl. Acad. Sci. U.S.A., 89, 3605-3609.
20. LEE, Y.-M., BEINBORN, M., MCBRIDE, E.W., LU, M., KOLAKOWSKI, Jr, L.F. & KOPIN, A.S. (1993). The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. J. Biol. Chem., 268, 8164-8169.
21. LOTTI, V.J. & CHANG, R.S.L. (1989). A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur. J. Pharmacol., 162, 273-280.
22. NAKATA, H., MATSUI, T., ITO, M., TANIGUCHI, T., NARIBAYASHI, Y., ARIMA, N., NAKAMURA, A., KINOSHITA, Y., CHIHARA, K., HOSODA, S. & CHIBA, T. (1992). Cloning and characterization of gastrin receptor from ECL carcinoid tumour of Mastomys natalensis. Biochem. Biophys. Res. Commun., 187, 1151-1157.
23. PATEL, M. & SPRAGGS, C.F. (1992). Functional comparison of gastrin/cholecystokinin receptors in isolated preparations of gastric mucosa and ileum. Br. J. Pharmacol., 106, 275-282.
24. PISEGNA, J.R., DE WEERTH, A., HUPPI, K. & WANK, S.A. (1992). Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. Biochem. Biophys. Res. Commun., 189, 296-303.
25. PRESTI, M.E. & GARDNER, J.D. (1993). Receptor antagonists for gastrointestinal peptides. Am. J. Physiol., 264, G399-G406.
26. PRINZ, C., SCOTT, D.R., HURWITZ, D., HELANDER, H.F. & SACHS, G. (1994). Gastrin effects on isolated rat enterochromaffin-like cells in primary culture. Am. J. Physiol., 267, G663-G675.
27. REHFELD, J.F. (1981). Four basic characteristics of the gastrin-CCK system. Am. J. Physiol., 240, G255-G266.
28. ROBERTS, S.P., WATT, G.F., GERSKOWITCH, V.P., HULL, R.A.D. SHANKLEY, N.P. & BLACK, J.W. (1995). Antagonism of pentagastrin responses by L-365,260 in rat, guinea-pig and mouse isolated gastric tissue assays: evidence for variable expression of two CCK/gastrin receptors. Br. J. Pharmacol., 114, 220P.
29. SANDVIK, A.K., WALDUM, H.L., KLEVELAND, P.M. & SCHULZE-SOEGNEN, B. (1987). Gastrin produces an immediate and dose dependent histamine release preceding acid secretion in the totally isolated, vascularly perfused rat stomach. Scand. J. Gastroenterol., 22, 803-808.
30. SAVARESE, T.M. & FRASER, C.M. (1992). In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem. J., 283, 1-19.
31. SHANKLEY, N.P. (1985). Pharmacological Analysis of the Regulators of Gastric Acid Secretion. University of London Ph.D. thesis.
32. SHANKLEY, N.P., WELSH, J.W. & BLACK, J.W. (1992). Histamine dependence of pentagastrin-stimulated gastric acid secretion in rats. Yale J. Biol. Med., 65, 613-619.
33. SNEDECOR, G.W. & COCHRAN, W.G. (1989). Statistical Methods. Iowa, U.S.A.: Iowa State University Press.
34. SONG, I., BROWN, D.R., WILTSHIRE, R.N., GANTZ, I., TRENT, J.M. & YAMADA, T. (1993). The human gastrin/cholecystokinin type B receptor gene: Alternative splice donor site in exon 4 generates two variant mRNAs. Proc. Natl. Acad. Sci. U.S.A., 90, 9085-9089.
35. SZELENYI, I. & VERGIN, M. (1980). Cholinergic pathway of gastric acid secretion in the isolated whole stomach of the mouse. Pharmacology, 21, 268-276.
36. WANK, S.A., PISEGNA, J.R. & DE WEERTH, A. (1992). Brain and gastrointestinal cholecystokinin receptor family: Structure and functional expression. Proc. Natl. Acad. Sci. U.S.A., 89, 8691-8695.
37. WANK, S.A., PISEGNA, J.R. & POIROT, S.S. (1994). Functional significance of potential splice variants of the human cholecystokinin (CCK) B receptor. Gastroenterol., 106, A850.
38. WELSH, N.J. (1992). Comparative Pharmacological Analysis of the Major Mediators Regulating Gastric Acid Secretion in Rodents. University of London Ph.D. thesis.
39. WELSH, N.J., SHANKLEY, N.P. & BLACK, J.W. (1992a). Evidence that pentagastrin acts both directly and indirectly by releasing histamine to stimulate gastric acid secretion in the rat. Br. J. Pharmacol., 106, 7P.
40. B estimates in lumen-perfused stomach assays from guinea-pig, rat and mouse. Br. J. Pharmacol., 106, 98P.
41. WELSH, N.J., SHANKLEY, N.P. & BLACK, J.W. (1993). Comparative study of the control of basal acid output from rodent isolated stomachs. Br. J. Pharmacol., 109, 941-945.
42. WELSH, N.J., SHANKLEY, N.P. & BLACK, J.W. (1995). Application of a model to explore interspecies differences in acetylcholine M-receptor-stimulated gastric acid secretion. Br. J. Pharmacol., 115, 961-968.
43. WOODRUFF, G.N. & HUGHES, J. (1991). Cholecystokinin antagonists. Ann. Rev. Toxicol., 31, 469-501.